These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 15221345)
1. Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells. Skaletz-Rorowski A; Pinkernell K; Sindermann JR; Schriever C; Müller JG; Eschert H; Breithardt G Basic Res Cardiol; 2004 Jul; 99(4):272-8. PubMed ID: 15221345 [TBL] [Abstract][Full Text] [Related]
2. PKC delta-induced activation of MAPK pathway is required for bFGF-stimulated proliferation of coronary smooth muscle cells. Skaletz-Rorowski A; Eschert H; Leng J; Stallmeyer B; Sindermann JR; Pulawski E; Breithardt G Cardiovasc Res; 2005 Jul; 67(1):142-50. PubMed ID: 15949478 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481 [TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Chua CC; Rahimi N; Forsten-Williams K; Nugent MA Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogen-activated protein kinase signalling pathways in human dermal fibroblasts. Zhang GY; Li X; Yi CG; Pan H; He GD; Yu Q; Jiang LF; Xu WH; Li ZJ; Ding J; Lin DS; Gao WY Exp Dermatol; 2009 Nov; 18(11):947-53. PubMed ID: 19397700 [TBL] [Abstract][Full Text] [Related]
6. Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells. Rauch BH; Millette E; Kenagy RD; Daum G; Clowes AW Circ Res; 2004 Feb; 94(3):340-5. PubMed ID: 14670838 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of capillary endothelial cells for basic fibroblast growth factor-induced paracrine signaling. Lee TH; Lee HC; Son YS; Kang MA; Park MJ; Nam MJ; Lee SH; Hong SI Endothelium; 2006; 13(3):191-203. PubMed ID: 16840175 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension. Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370 [TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling: localization and expression of basic fibroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia. Sangha RK; Li XF; Shams M; Ahmed A Lab Invest; 1997 Oct; 77(4):389-402. PubMed ID: 9354773 [TBL] [Abstract][Full Text] [Related]
10. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II induces proliferation of human cerebral artery smooth muscle cells through a basic fibroblast growth factor (bFGF) dependent mechanism. Wang Z; Rao PJ; Shillcutt SD; Newman WH Neurosci Lett; 2005 Jan; 373(1):38-41. PubMed ID: 15555773 [TBL] [Abstract][Full Text] [Related]
13. Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells. Pardo OE; Arcaro A; Salerno G; Tetley TD; Valovka T; Gout I; Seckl MJ Oncogene; 2001 Nov; 20(52):7658-67. PubMed ID: 11753643 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension. Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979 [TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells. Sperinde GV; Nugent MA Biochemistry; 1998 Sep; 37(38):13153-64. PubMed ID: 9748322 [TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A. Motamed K; Blake DJ; Angello JC; Allen BL; Rapraeger AC; Hauschka SD; Sage EH J Cell Biochem; 2003 Oct; 90(2):408-23. PubMed ID: 14505356 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium. Carbajo-Lozoya J; Lutz S; Feng Y; Kroll J; Hammes HP; Wieland T Cell Signal; 2012 Jun; 24(6):1261-9. PubMed ID: 22374305 [TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway. Finetti F; Donnini S; Giachetti A; Morbidelli L; Ziche M Circ Res; 2009 Sep; 105(7):657-66. PubMed ID: 19713533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]